Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.
Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the type of intervention and added new contact information for Darren Sigal and Ahmed Kaseb, while removing the previous type of intervention from the earlier version.SummaryDifference1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, with a reference to the Contacts and Locations section.SummaryDifference4%
- Check53 days agoChange DetectedThe website has added a 'Show less' option, while several detailed data fields and download options related to clinical study information have been removed.SummaryDifference6%
- Check61 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and displaying detailed participant and study information, while removing the option to show less content.SummaryDifference6%
- Check75 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.